DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on September 9, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.

The entire rule text may be found here: https://www.federalregister.gov/articles/2014/08/22/2014-19922/schedules-of-controlled-substances-rescheduling-of-hydrocodone-combination-products-from-schedule



More Latest News

Important Message Regarding License Expiration Dates
May 28, 2020

State Surgeon General Dr. Scott A. Rivkees issued Emergency Order DOH No. 20-008 extending the licensure renewal expiration with renewal deadlines between May 31, 2020 and July 31, 2020. Continue reading


2020 Podiatric Physician License Renewal
April 10, 2020

Please Click Here To Learn More About Emergency Rule 64B18ER20-19 Affecting Podiatric Physicians Continue reading